Find Dasatinib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 302962-49-8, Sprycel, Bms-354825, Dasatinib anhydrous, Bms 354825, Bms354825
Molecular Formula
C22H26ClN7O2S
Molecular Weight
488.0  g/mol
InChI Key
ZBNZXTGUTAYRHI-UHFFFAOYSA-N
FDA UNII
X78UG0A0RN

Dasatinib
A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB.
Dasatinib anhydrous is a Kinase Inhibitor. The mechanism of action of dasatinib anhydrous is as a Protein Kinase Inhibitor, and Cytochrome P450 3A4 Inhibitor.
1 2D Structure

Dasatinib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
2.1.2 InChI
InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)
2.1.3 InChI Key
ZBNZXTGUTAYRHI-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
2.2 Other Identifiers
2.2.1 UNII
X78UG0A0RN
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (18f)-n-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide

2. 354825, Bms

3. Bms 354825

4. Bms-354825

5. Bms354825

6. N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide

7. Sprycel

2.3.2 Depositor-Supplied Synonyms

1. 302962-49-8

2. Sprycel

3. Bms-354825

4. Dasatinib Anhydrous

5. Bms 354825

6. Bms354825

7. Dasatinib (bms-354825)

8. Dasatinib (anhydrous)

9. N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide

10. N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide

11. N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide

12. N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide

13. Anh. Dasatinib

14. Anhydrous Dasatinib

15. Dasatinib (anh.)

16. Chembl1421

17. X78ug0a0rn

18. Chebi:49375

19. Dasatinib D8

20. Nsc732517

21. Nsc-732517

22. Nsc-759877

23. Ncgc00181129-01

24. Dsstox_cid_20979

25. Dsstox_rid_79608

26. Dsstox_gsid_40979

27. 5-thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-

28. Dasatinibum

29. Bms-354825 Hydrate

30. 5-thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-

31. Smr002529551

32. Cas-302962-49-8

33. 302962-49-8 Pound Not863127-77-9

34. Dasatinib [usan:inn]

35. Unii-x78ug0a0rn

36. Bms Dasatinib

37. 1n1

38. Kinome_3650

39. Dasatinib (jan/inn)

40. Dasatinib [inn]

41. Dasatinib [mi]

42. N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide

43. Sprycel (bristol Meyers)

44. Dasatinib [who-dd]

45. Schembl8226

46. Dasatinib,bms-354825

47. Mls003915609

48. Mls004774145

49. Mls006010904

50. Dasatinib - Bms-354825

51. Gtpl5678

52. Dtxsid4040979

53. Bdbm13216

54. Cid_3062316

55. Ex-a401

56. 5-thiazolecarboxamide, Monohydrate

57. Bcpp000263

58. Hms2043n05

59. Hms3244a05

60. Hms3244a06

61. Hms3244b05

62. Hms3265c19

63. Hms3265c20

64. Hms3265d19

65. Hms3265d20

66. Hms3654k05

67. Hms3744c11

68. Pharmakon1600-01502275

69. Bcp01797

70. Zinc3986735

71. Tox21_112736

72. Mfcd11046566

73. Nsc759877

74. Nsc800087

75. S1021

76. Akos015902363

77. Tox21_112736_1

78. Bcp9000589

79. Bms 345825

80. Ccg-264779

81. Cs-0100

82. Db01254

83. Gs-6548

84. Nsc-800087

85. Sb17284

86. Ncgc00181129-02

87. Ncgc00181129-03

88. Ncgc00181129-05

89. Ncgc00181129-06

90. Ncgc00181129-07

91. Ncgc00181129-12

92. Ncgc00181129-14

93. Ncgc00181129-22

94. Ncgc00481571-01

95. 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-n-(2-chloro-6-methylphenyl)thiazole-5-carboxamide

96. Ac-22749

97. Bcb03_000715

98. Bms 35482513

99. Hy-10181

100. N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide

101. Am20080877

102. D5949

103. Ft-0650671

104. Sw208076-5

105. Ec-000.2122

106. D-3307

107. D03658

108. Ab01273956-01

109. Ab01273956-02

110. Ab01273956_03

111. Ar-270/43507994

112. Q419940

113. Sr-00000000554

114. Q-101345

115. Sr-00000000554-5

116. Brd-k49328571-001-05-1

117. Brd-k49328571-001-07-7

118. Bms-354825;bms354825;bms 354825

119. Z2786158251

120. N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl}amino)-1,3-thiazole-5-carboxamide

121. N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide

2.4 Create Date
2005-08-09
3 Chemical and Physical Properties
Molecular Weight 488.0 g/mol
Molecular Formula C22H26ClN7O2S
XLogP33.6
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count7
Exact Mass487.1557220 g/mol
Monoisotopic Mass487.1557220 g/mol
Topological Polar Surface Area135 Ų
Heavy Atom Count33
Formal Charge0
Complexity642
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameSprycel
PubMed HealthDasatinib (By mouth)
Drug ClassesAntineoplastic Agent, Immunological Agent
Drug LabelSPRYCEL (dasatinib) is a kinase inhibitor. The chemical name for dasatinib is N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate. The molecular formula is C22H26ClN7O2...
Active IngredientDasatinib
Dosage FormTablet
Routeoral; Oral
Strength140mg; 100mg; 50mg; 80mg; 70mg; 20mg
Market StatusPrescription
CompanyBristol Myers Squibb

2 of 2  
Drug NameSprycel
PubMed HealthDasatinib (By mouth)
Drug ClassesAntineoplastic Agent, Immunological Agent
Drug LabelSPRYCEL (dasatinib) is a kinase inhibitor. The chemical name for dasatinib is N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate. The molecular formula is C22H26ClN7O2...
Active IngredientDasatinib
Dosage FormTablet
Routeoral; Oral
Strength140mg; 100mg; 50mg; 80mg; 70mg; 20mg
Market StatusPrescription
CompanyBristol Myers Squibb

4.2 Drug Indication

For the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia with resistance or intolerance to prior therapy. Also indicated for the treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukemia with resistance or intolerance to prior therapy.


FDA Label


Sprycel is indicated for the treatment of paediatric patients with:

newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukaemia in chronic phase (Ph+ CML CP) or Ph+ CML CP resistant or intolerant to prior therapy including imatinib. newly diagnosed Ph+ acute lymphoblastic leukaemia (ALL) in combination with chemotherapy.

Sprycel is indicated for the treatment of adult patients with:

- newly diagnosed Philadelphia-chromosome-positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase;

- chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate;

- Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.

Sprycel is indicated for the treatment of paediatric patients with:

- newly diagnosed Ph+ CML in chronic phase (Ph+ CML-CP) or Ph+ CML-CP resistant or intolerant to prior therapy including imatinib.


Treatment of Philadelphia-chromosome (BCR-ABL translocation)-positive acute lymphoblastic leukaemia, Treatment of Philadelphia-chromosome (BCR-ABL translocation)-positive chronic myeloid leukaemia


Dasatinib Accord is indicated for the treatment of adult patients with:

Ph+ acute lymphoblastic leukaemia (ALL) with resistance or intolerance to prior therapy.

Dasatinib Accord is indicated for the treatment of paediatric patients with:

newly diagnosed Ph+ ALL in combination with chemotherapy.


Dasatinib Accordpharma is indicated for the treatment of adult patients with:

newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase.

chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib.

Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.

Dasatinib Accordpharma is indicated for the treatment of paediatric patients with:

newly diagnosed Ph+ CML in chronic phase (Ph+ CML-CP) or Ph+ CML-CP resistant or intolerant to prior therapy including imatinib.

newly diagnosed Ph+ ALL in combination with chemotherapy.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor


5.2 MeSH Pharmacological Classification

Protein Kinase Inhibitors

Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)


Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
DASATINIB ANHYDROUS
5.3.2 FDA UNII
X78UG0A0RN
5.3.3 Pharmacological Classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]
5.4 ATC Code

L01EA02


L01EA02


L01EA02


L01XE06

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


L - Antineoplastic and immunomodulating agents

L01 - Antineoplastic agents

L01E - Protein kinase inhibitors

L01EA - Bcr-abl tyrosine kinase inhibitors

L01EA02 - Dasatinib


5.5 Absorption, Distribution and Excretion

Route of Elimination

Dasatinib is extensively metabolized in humans, primarily by the cytochrome P450 enzyme 3A4. Elimination is primarily via the feces.


Volume of Distribution

2505 L


5.6 Metabolism/Metabolites

Dasatinib is extensively metabolized in humans, primarily by the cytochrome P450 enzyme 3A4


5.7 Biological Half-Life

The overall mean terminal half-life of dasatinib is 3-5 hours.


5.8 Mechanism of Action

Dasatinib, at nanomolar concentrations, inhibits the following kinases: BCR-ABL, SRC family (SRC, LCK, YES, FYN), c-KIT, EPHA2, and PDGFRβ. Based on modeling studies, dasatinib is predicted to bind to multiple conformations of the ABL kinase. In vitro, dasatinib was active in leukemic cell lines representing variants of imatinib mesylate sensitive and resistant disease. Dasatinib inhibited the growth of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) cell lines overexpressing BCR-ABL. Under the conditions of the assays, dasatinib was able to overcome imatinib resistance resulting from BCR-ABL kinase domain mutations, activation of alternate signaling pathways involving the SRC family kinases (LYN, HCK), and multi-drug resistance gene overexpression.


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"DASATINIB","year":"2021","qtr":"Q1","strtotime":1611685800,"product":"DASATINIB ANHYDROUS IH (GROUP:B","address":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"TOKYO","customer":"CBC GROUP","customerCountry":"JAPAN","quantity":"65.00","actualQuantity":"65","unit":"KGS","unitRateFc":"9724.5","totalValueFC":"639981.6","currency":"USD","unitRateINR":720095.86153846153,"date":"27-Jan-2021","totalValueINR":"46806231","totalValueInUsd":"639981.6","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"8189452","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"DASATINIB MONOHYDRATE","year":"2021","qtr":"Q2","strtotime":1618425000,"product":"DASATINIB MONOHYDRATE (OTHER)(TAX INVB LPL\/0007\/21-22 DT.03.04.2021 GSTN24AABC M3101A1ZJ)PHARMACEUTICAL RAW MATERIAL","address":"407\/408,SHARDA CHAMBERS,NEW MARINE LINES,","city":"MUMBAI, MAHARASHTRA.","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"LAECPHSA","customerCountry":"ARGENTINA","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"2852.5","totalValueFC":"11042.2","currency":"USD","unitRateINR":205520.72750000001,"date":"15-Apr-2021","totalValueINR":"822082.91","totalValueInUsd":"11042.2","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"1121947","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408,SHARDA CHAMBERS,NEW MARINE LINES,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1624645800,"product":"DASATINIB","address":"N0 116\/117, KIADB INDUSTRIAL AREA,JIGANI","city":"BANGALORE","supplier":"ACEBRIGHT GROUP","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"JSC PHARMASYNTEZ","customerCountry":"RUSSIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"10086.2","totalValueFC":"4940.5","currency":"USD","unitRateINR":726707.12,"date":"26-Jun-2021","totalValueINR":"363353.56","totalValueInUsd":"4940.5","indian_port":"BANGALORE AIR","hs_no":"29420090","bill_no":"2692196","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"N0 116\/117, KIADB INDUSTRIAL AREA,JIGANI, BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1631471400,"product":"DASATINIB ANHYDROUS IH (BATCH NOS:DO2012","address":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"LABORATORIOS VARIFARMA S.A.","customerCountry":"ARGENTINA","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"3900","totalValueFC":"15076.9","currency":"USD","unitRateINR":277250,"date":"13-Sep-2021","totalValueINR":"1109000","totalValueInUsd":"15076.9","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"4550936","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1642962600,"product":"DASATINIB","address":"304, Town Centre, Andheri Kurla Road, Andheri East","city":"MUMBAI","supplier":"MAC-CHEM PRODUCTS (INDIA) PVT.LTD","supplierCountry":"INDIA","foreign_port":"TIRANA","customer":"LEKLI SH, P,K","customerCountry":"ALBANIA","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"10300","totalValueFC":"1020.2","currency":"USD","unitRateINR":760000,"date":"24-Jan-2022","totalValueINR":"76000","totalValueInUsd":"1020.2","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"7709380","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ALBANIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"304, Town Centre, Andheri Kurla Road, Andheri East, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645122600,"product":"DASATINIB ANHYDROUS IH BATCH NOS: DO1908","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"LAFEDAR SA","customerCountry":"ARGENTINA","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"6984","totalValueFC":"1187.3","currency":"USD","unitRateINR":445000,"date":"18-Feb-2022","totalValueINR":"89000","totalValueInUsd":"1187.3","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"8330229","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1651257000,"product":"DASATINIB IH","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"TUNIS","customer":"TO THE ORDER OF","customerCountry":"TUNISIA","quantity":"8.40","actualQuantity":"8.4","unit":"KGS","unitRateFc":"5500","totalValueFC":"45898.6","currency":"USD","unitRateINR":412261.90476190473,"date":"30-Apr-2022","totalValueINR":"3463000","totalValueInUsd":"45898.6","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"1077429","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TUNISIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1652293800,"product":"DASATINIB ANHYDROUS IH BATCH NOS: DO2204","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"TO THE ORDER OF","customerCountry":"ARGENTINA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"4074","totalValueFC":"11606.3","currency":"USD","unitRateINR":299000,"date":"12-May-2022","totalValueINR":"897000","totalValueInUsd":"11606.3","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"1337703","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1656873000,"product":"DASATINIB ANHYDROUS IH BATCH NO.DO210100","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"TO THE ORDER OF","customerCountry":"ARGENTINA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"4365","totalValueFC":"12425.1","currency":"USD","unitRateINR":329333.33333333331,"date":"04-Jul-2022","totalValueINR":"988000","totalValueInUsd":"12425.1","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"2581112","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1660761000,"product":"PHARMACEUTICAL RAW MATERIAL - DASATINIB","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"LAECPHSA","customerCountry":"ARGENTINA","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"2910","totalValueFC":"11223.2","currency":"USD","unitRateINR":223250,"date":"18-Aug-2022","totalValueINR":"893000","totalValueInUsd":"11223.2","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"3563727","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1667500200,"product":"DASATINIB MONOHYDRATE","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"BANK ASIA LIMITED","customerCountry":"BANGLADESH","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"12000","totalValueFC":"12020.2","currency":"USD","unitRateINR":981000,"date":"04-Nov-2022","totalValueINR":"981000","totalValueInUsd":"12020.2","indian_port":"HYDERABAD AIR","hs_no":"29141990","bill_no":"5250412","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1668450600,"product":"DASATINIB MONOHYDRATE (OTHER)(LUT (ARN)","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"LAECPHSA","customerCountry":"ARGENTINA","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"2910","totalValueFC":"11542.3","currency":"USD","unitRateINR":235500,"date":"15-Nov-2022","totalValueINR":"942000","totalValueInUsd":"11542.3","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"5466419","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1672684200,"product":"DASATINIB BATCH NO;DSTG22001","address":"N0 116\/117, KIADB INDUSTRIAL AREA, ,JIGANI 2ND PHASE","city":"BANGALORE,KARNATAKA","supplier":"CDYMAX (INDIA) PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"KUALA LUMPUR - INT\\'L","customer":"NOVUGEN ONCOLOGY SDN.BHD","customerCountry":"MALAYSIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"7500","totalValueFC":"14652.7","currency":"USD","unitRateINR":599000,"date":"03-Jan-2023","totalValueINR":"1198000","totalValueInUsd":"14652.7","indian_port":"BANGALORE AIR","hs_no":"29349990","bill_no":"6652213","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"MALAYSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"N0 116\/117, KIADB INDUSTRIAL AREA, ,JIGANI 2ND PHASE, BANGALORE,KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1675967400,"product":"DASATINIB MONOHYDRATE (OTHER) (LUT (ARN","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SINGAPORE","customer":"LEPTLT","customerCountry":"SINGAPORE","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"2910","totalValueFC":"11308.9","currency":"USD","unitRateINR":233500,"date":"10-Feb-2023","totalValueINR":"934000","totalValueInUsd":"11308.9","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"7684234","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SINGAPORE","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676485800,"product":"DASATINIB MONOHYDRATE","address":"201, OM SHREE SAINATH CHS, PLOT NO 39, SECTOR-2, CHARKOP,","city":"KANDIVALI WEST, MUMBAI.","supplier":"SS PHARMA","supplierCountry":"INDIA","foreign_port":"MOSCOW","customer":"LIMITED LIABILITY COMPANY POLARIS","customerCountry":"RUSSIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"189750","totalValueFC":"4588.9","currency":"INR","unitRateINR":189500,"date":"16-Feb-2023","totalValueINR":"379000","totalValueInUsd":"4588.9","indian_port":"BOMBAY AIR","hs_no":"29349990","bill_no":"7821996","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"201, OM SHREE SAINATH CHS, PLOT NO 39, SECTOR-2, CHARKOP,, KANDIVALI WEST, MUMBAI.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679250600,"product":"DASATINIB MONOHYDRATE (OTHER) ( GST TAX","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SINGAPORE","customer":"IWLOPRLT","customerCountry":"SINGAPORE","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"2910","totalValueFC":"11477.2","currency":"USD","unitRateINR":236000,"date":"20-Mar-2023","totalValueINR":"944000","totalValueInUsd":"11477.2","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"8597123","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SINGAPORE","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1684089000,"product":"PHARMA INGREDIENTS DASATINIB MONOHYDRATE IN HOUSE","address":"30, AROHI VILLA, S.P. RING ROAD, BOPAL,","city":"AHMEDABAD","supplier":"GREENCROSS EXPORT PRIVATE ","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"TO THE ORDER","customerCountry":"RUSSIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"10000","totalValueFC":"48830.8","currency":"USD","unitRateINR":803600,"date":"15-May-2023","totalValueINR":"4018000","totalValueInUsd":"48830.8","indian_port":"AHMEDABAD AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"30, AROHI VILLA, S.P. RING ROAD, BOPAL,, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1685471400,"product":"DASATINIB MONOHYDRATE TAX INV 9240000","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SINGAPORE","customer":"IWLOG","customerCountry":"SINGAPORE","quantity":"8.00","actualQuantity":"8","unit":"KGS","unitRateFc":"2910","totalValueFC":"22932.7","currency":"USD","unitRateINR":235875,"date":"31-May-2023","totalValueINR":"1887000","totalValueInUsd":"22932.7","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SINGAPORE","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1694457000,"product":"DASATINIB IHS","address":"20TH K M, HOSUR ROAD,,ELECTRONIC C","city":"BANGALORE,KARNATAKA","supplier":"BIOCON","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"M\/S.","customerCountry":"EGYPT","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"2950","totalValueFC":"28948.9","currency":"USD","unitRateINR":240300,"date":"12-Sep-2023","totalValueINR":"2403000","totalValueInUsd":"28948.9","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"3866780","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"20TH K M, HOSUR ROAD,,ELECTRONIC C, BANGALORE,KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1699900200,"product":"DASATINIB ANHYDROUS IH","address":"HETERO CORPORATE, NO. 7-2-A2,","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"TO THE ORDER OF.,","customerCountry":"ARGENTINA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"3201","totalValueFC":"15539.6","currency":"USD","unitRateINR":258800,"date":"14-Nov-2023","totalValueINR":"1294000","totalValueInUsd":"15539.6","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"5347615","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2,, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705429800,"product":"DASATINIB MONOHYDRATE (OTHER)(TAX INV MH1160000466 DT 02.01.2024)","address":"407\/408,SHARDA CHAMBERS,","city":"MUMBAI, MAHARASHTRA.","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"LABECPHSA","customerCountry":"ARGENTINA","quantity":"8.00","actualQuantity":"8","unit":"KGS","unitRateFc":"2822.7","totalValueFC":"22236.9","currency":"USD","unitRateINR":231018.25375,"date":"17-Jan-2024","totalValueINR":"1848146.03","totalValueInUsd":"22236.9","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"6801357","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"407\/408,SHARDA CHAMBERS,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709663400,"product":"DASATINIB MONOHYDRATE","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"BORYUNG CO.,LTD","customerCountry":"KOREA, REPUBLIC OF","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"15000","totalValueFC":"14783.8","currency":"USD","unitRateINR":1227585.49,"date":"06-Mar-2024","totalValueINR":"1227585.49","totalValueInUsd":"14783.8","indian_port":"Hyderabad Air","hs_no":"29141990","bill_no":"8094234","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1717957800,"product":"DASATINIB","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"MALTA","customer":"PHARMACARE PREMIUM","customerCountry":"MALTA","quantity":"2.50","actualQuantity":"2.5","unit":"KGS","unitRateFc":"8000","totalValueFC":"19558","currency":"USD","unitRateINR":653076.80000000005,"date":"10-Jun-2024","totalValueINR":"1632692","totalValueInUsd":"19558","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"1550224","productDescription":"API","marketType":"REGULATED MARKET","country":"MALTA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722364200,"product":"DASATINIB (MONOHYDRATE)","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"MASUNG LS CO.,LTD,","customerCountry":"REPUBLIC OF KOREA","quantity":"3.30","actualQuantity":"3.3","unit":"KGS","unitRateFc":"10000","totalValueFC":"32446.7","currency":"USD","unitRateINR":821895.15151515161,"date":"31-Jul-2024","totalValueINR":"2712254","totalValueInUsd":"32446.7","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"2859460","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723660200,"product":"(REWARD ITEM) DASATINIB MONOHYDRATE( TAXINV. NO.VLS\/EXP\/016\/24-25 DT-09-08-2024)","address":"01-076\/3\/1A\/F1\/NR,1ST FLOOR, GANGA","city":"N\/A","supplier":"VANNSH LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"M\/S. LABORATORIO ASPEN S.A.","customerCountry":"ARGENTINA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"2500","totalValueFC":"4707","currency":"USD","unitRateINR":197408.5,"date":"15-Aug-2024","totalValueINR":"394817","totalValueInUsd":"4707","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"3228576","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"01-076\/3\/1A\/F1\/NR,1ST FLOOR, GANGA, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723660200,"product":"(REWARD ITEM) DASATINIB MONOHYDRATE( TAXINV. NO.VLS\/EXP\/016\/24-25 DT-09-08-2024)","address":"01-076\/3\/1A\/F1\/NR,1ST FLOOR, GANGA","city":"N\/A","supplier":"VANNSH LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"M\/S. LABORATORIO KEMEX SA","customerCountry":"ARGENTINA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"2500","totalValueFC":"4707","currency":"USD","unitRateINR":197408.5,"date":"15-Aug-2024","totalValueINR":"394817","totalValueInUsd":"4707","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"3228236","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"01-076\/3\/1A\/F1\/NR,1ST FLOOR, GANGA, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726511400,"product":"DASATINIB BATCH NO;DSTG22006","address":"N0 116\/117, KIADB INDUSTRIAL AREA,","city":"BANGALORE","supplier":"CDYMAX (INDIA) PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"M\/S,BIOKHIMIK JSC","customerCountry":"RUSSIA","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"391510","totalValueFC":"6670.2","currency":"INR","unitRateINR":372647.58000000002,"date":"17-Sep-2024","totalValueINR":"558971.37","totalValueInUsd":"6670.2","indian_port":"Bangalore Air","hs_no":"29349990","bill_no":"4065685","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"N0 116\/117, KIADB INDUSTRIAL AREA,, BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726857000,"product":"DASATINIB ANHYDROUS IH (GST TAX INV. SI3624203123 DT: 26.07.2024)","address":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"ORBIT SHIPPING SERVICES LLC","customerCountry":"UNITED ARAB EMIRATES","quantity":"2.80","actualQuantity":"2.8","unit":"KGS","unitRateFc":"4500","totalValueFC":"13757.6","currency":"EUR","unitRateINR":411750,"date":"21-Sep-2024","totalValueINR":"1152900","totalValueInUsd":"13757.6","indian_port":"Bombay Air","hs_no":"29349990","bill_no":"4220289","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727634600,"product":"DASATINIB MONOHYDRATE (OTHER) (OTHER)(LUT(ARN)NO: AD270324101144O DT: 15\/03\/2024)(TAX INV# MH2411600295 DT:27","address":"407\/408,SHARDA CHAMBERS,","city":"MUMBAI, MAHARASHTRA.","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"LABECPHSA","customerCountry":"ARGENTINA","quantity":"8.00","actualQuantity":"8","unit":"KGS","unitRateFc":"2822.7","totalValueFC":"22023","currency":"USD","unitRateINR":230694.535,"date":"30-Sep-2024","totalValueINR":"1845556.28","totalValueInUsd":"22023","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"4486362","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"407\/408,SHARDA CHAMBERS,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640802600,"product":"DASATINIB ANHYDROUS","address":"882\/1-871, NEAR KANKAVATI ,VILLAGE-","city":"AHMEDABAD, GUJARAT","supplier":"TEVA API","supplierCountry":"CROATIA","foreign_port":"N\/A","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"9500","totalValueFC":"9717.1","currency":"USD","unitRateINR":"732925","date":"30-Dec-2021","totalValueINR":"732925","totalValueInUsd":"9717.1","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29341000","bill_no":"1005284","productDescription":"API","marketType":"REGULATED MARKET","country":"CROATIA","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"PIET HEIN BUILDING, PIET HEINKADE 1071019 GM AMSTERDAM THE NETHERLANDS NL","customerAddress":"882\/1-871, NEAR KANKAVATI ,VILLAGE-"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732127400,"product":"DASATINIB ANHYDROUS IH(B\/N:DO23080008,009,010 & 011)(EXP.VIDE S\/B:4557466,DT:11-10-2023, S\/N:SI3623224289,DT:29-09-2023)","address":"HETERO CORPORATE, NO. 7-2-A2,","city":"HYDERABAD","supplier":"CBC GROUP","supplierCountry":"INDIA","foreign_port":"TOKYO - NARITA","customer":"HETERO DRUGS","customerCountry":"INDIA","quantity":"80.00","actualQuantity":"80","unit":"KGS","unitRateFc":"8000","totalValueFC":"646915.2","currency":"USD","unitRateINR":"682400","date":"21-Nov-2024","totalValueINR":"54592000","totalValueInUsd":"646915.2","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"6800744","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"TOKYO - NARITA","supplierAddress":"2-15-13, TSUKISHIMA CHUO KU TOKYO 104-0052 JP","customerAddress":"HETERO CORPORATE, NO. 7-2-A2,"}]
27-Jan-2021
21-Nov-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Co-Processed Excipients

read-more
read-more

Lubricants & Glidants

read-more
read-more

Topical

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Empty Capsules

read-more
read-more

Solubilizers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Taste Masking

read-more
read-more

Coloring Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

API Stability Enhancers

read-more
read-more

Emulsifying Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DASATINIB

US Patent Number : 8680103*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-08-04

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DASATINIB

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DASATINIB

US Patent Number : 8680103*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-08-04

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DASATINIB

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

blank

05

NANOCOPOEIA

arrow
Antibody Engineering
Not Confirmed

NANOCOPOEIA

Country
arrow
Antibody Engineering
Not Confirmed

DASATINIB

US Patent Number : 11324745

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3769

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

blank

06

NANOCOPOEIA

arrow
Antibody Engineering
Not Confirmed

NANOCOPOEIA

Country
arrow
Antibody Engineering
Not Confirmed

DASATINIB

US Patent Number : 11202778

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3772

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

blank

07

NANOCOPOEIA

arrow
Antibody Engineering
Not Confirmed

NANOCOPOEIA

Country
arrow
Antibody Engineering
Not Confirmed

DASATINIB

US Patent Number : 11298356

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216099

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

blank

08

NANOCOPOEIA

arrow
Antibody Engineering
Not Confirmed

NANOCOPOEIA

Country
arrow
Antibody Engineering
Not Confirmed

DASATINIB

US Patent Number : 11324745

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3769

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

blank

09

NANOCOPOEIA

arrow
Antibody Engineering
Not Confirmed

NANOCOPOEIA

Country
arrow
Antibody Engineering
Not Confirmed

DASATINIB

US Patent Number : 11202778

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3772

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

blank

10

NANOCOPOEIA

arrow
Antibody Engineering
Not Confirmed

NANOCOPOEIA

Country
arrow
Antibody Engineering
Not Confirmed

DASATINIB

US Patent Number : 11202778

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3770

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

US Exclusivities

read-more
read-more

01

arrow
Antibody Engineering
Not Confirmed

APOTEX

Canada
arrow
Antibody Engineering
Not Confirmed

DASATINIB

Exclusivity Code : PC

Exclusivity Expiration Date : 2025-03-02

Application Number : 202103

Product Number : 4

Exclusivity Details :

blank

02

arrow
Antibody Engineering
Not Confirmed

APOTEX

Canada
arrow
Antibody Engineering
Not Confirmed

DASATINIB

Exclusivity Code : PC

Exclusivity Expiration Date : 2025-03-02

Application Number : 202103

Product Number : 3

Exclusivity Details :

blank

03

arrow
Antibody Engineering
Not Confirmed

APOTEX

Canada
arrow
Antibody Engineering
Not Confirmed

DASATINIB

Exclusivity Code : PC

Exclusivity Expiration Date : 2025-03-02

Application Number : 202103

Product Number : 1

Exclusivity Details :

blank

04

arrow
Antibody Engineering
Not Confirmed

APOTEX

Canada
arrow
Antibody Engineering
Not Confirmed

DASATINIB

Exclusivity Code : PC

Exclusivity Expiration Date : 2025-03-02

Application Number : 202103

Product Number : 2

Exclusivity Details :

blank

05

arrow
Antibody Engineering
Not Confirmed

APOTEX

Canada
arrow
Antibody Engineering
Not Confirmed

DASATINIB

Exclusivity Code : PC

Exclusivity Expiration Date : 2025-03-02

Application Number : 203180

Product Number : 2

Exclusivity Details :

blank

06

arrow
Antibody Engineering
Not Confirmed

APOTEX

Canada
arrow
Antibody Engineering
Not Confirmed

DASATINIB

Exclusivity Code : PC

Exclusivity Expiration Date : 2025-03-02

Application Number : 203180

Product Number : 1

Exclusivity Details :

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DASATINIB

Exclusivity Code : ODE-164

Exclusivity Expiration Date : 2024-11-09

Application Number : 21986

Product Number : 1

Exclusivity Details :

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DASATINIB

Exclusivity Code : ODE-225

Exclusivity Expiration Date : 2025-12-21

Application Number : 21986

Product Number : 1

Exclusivity Details :

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DASATINIB

Exclusivity Code : ODE-164

Exclusivity Expiration Date : 2024-11-09

Application Number : 21986

Product Number : 2

Exclusivity Details :

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DASATINIB

Exclusivity Code : ODE-225

Exclusivity Expiration Date : 2025-12-21

Application Number : 21986

Product Number : 2

Exclusivity Details :

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty